(Q37995533)

26 August 2017

title

Clinical implications of growth hormone-secreting tumor subtypes (English)

1 reference

26 August 2017

author name string

Katja Kiseljak-Vassiliades

1

1 reference

26 August 2017

Shibana Shafi

2

1 reference

26 August 2017

Janice M Kerr

3

1 reference

26 August 2017

Tzu L Phang

4

1 reference

26 August 2017

B K Kleinschmidt-DeMasters

5

1 reference

26 August 2017

Margaret E Wierman

6

1 reference

26 August 2017

publication date

21 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

42

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

18-28

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9660-9

26 August 2017

exact match

0 references

cites work

The pathogenesis of pituitary tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Acromegaly pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

A consensus on criteria for cure of acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Guidelines for acromegaly management: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Treatment of acromegaly: future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Pituitary gland: Medical therapy for acromegaly: can we predict response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Classification and pathology of pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Growth hormone-secreting adenomas: pathology and cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Pituitary chromophobe adenomas consisting of prolactin cells: a histologic, immunocytological and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Keratins in health and cancer: more than mere epithelial cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Cadherins as Modulators of Cellular Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9660-9

Ultrastructural Classification of Pituitary Adenomas

21 January 2018

1 reference

12 December 2020

Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly

1 reference

12 December 2020

Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.

1 reference

12 December 2020

Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria

1 reference

12 December 2020

Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.

1 reference

12 December 2020

Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.

1 reference

12 December 2020

Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients

1 reference

12 December 2020

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

1 reference

12 December 2020

Presurgical Octreotide: treatment in acromegaly

1 reference

12 December 2020

Somatostatin analogs in acromegaly

1 reference

12 December 2020

In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide

1 reference

12 December 2020

Clinical features and growth fractions of pituitary adenomas

1 reference

12 December 2020

Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly

1 reference

12 December 2020

Expression of Glycoprotein Hormones and Intracytoplasmic Distribution of Cytokeratin in Growth Hormone-Producing Pituitary Adenomas

1 reference

12 December 2020

[Prognostic factors in the surgical management of acromegaly]

1 reference

12 December 2020

Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation

1 reference

12 December 2020

10.1007/S12020-012-9660-9

Identifiers

DOI

1 reference

26 August 2017

1 reference